- Business Wire•11 hours ago
Cytori Therapeutics, Inc. will provide a live webcast of its third quarter financial results and business update on Wednesday, November 9, 2016 at 5:30 PM Eastern Time.
- Business Wire•20 hours agoCytori Presents Scleroderma Clinical Trial Data at the 2016 American College of Rheumatology Annual Meeting
Cytori Therapeutics, Inc. will present data from its STAR Phase 3 clinical trial describing progress, preliminary blinded patient characteristics, and safety of adipose-derived regenerative cells for treatment of scleroderma hand dysfunction at the Annual Meeting of the American College of Rheumatology on November 15, 2016.
- Business Wire•3 days ago
Cytori Therapeutics, Inc. announced today the publication of preclinical safety and efficacy study data using Cytori Cell Therapy™ for combined radiation and thermal injury.
Cytori Therapeutics, Inc. (CYTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Day's Range||1.82 - 1.85|
|52wk Range||1.78 - 6.15|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.73|
|Avg Vol (3m)||121,932|
|Dividend & Yield||N/A (N/A)|